• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study.法国启动瞬感葡萄糖监测后 1 型或 2 型糖尿病患者急性糖尿病并发症发生率显著下降:RELIEF 研究。
Diabetes Care. 2021 Jun;44(6):1368-1376. doi: 10.2337/dc20-1690. Epub 2021 Apr 20.
2
Important Decrease in Hospitalizations for Acute Diabetes Events Following FreeStyle Libre System Initiation in People with Type 2 Diabetes on Basal Insulin Therapy in France.在法国,基础胰岛素治疗的2型糖尿病患者开始使用FreeStyle Libre系统后,急性糖尿病事件住院人数显著减少。
Diabetes Technol Ther. 2023 Jan;25(1):20-30. doi: 10.1089/dia.2022.0271. Epub 2022 Nov 24.
3
Reduced Acute Diabetes Events After FreeStyle Libre System Initiation in People 65 Years or Older with Type 2 Diabetes on Intensive Insulin Therapy in France.法国强化胰岛素治疗的 65 岁及以上 2 型糖尿病患者启用 FreeStyle Libre 系统后,急性糖尿病事件减少。
Diabetes Technol Ther. 2023 Jun;25(6):384-394. doi: 10.1089/dia.2023.0034.
4
Reduced Rate of Acute Diabetes Events with Flash Glucose Monitoring Is Sustained for 2 Years After Initiation: Extended Outcomes from the RELIEF Study.起始后 2 年持续降低急性糖尿病事件发生率:RELIEF 研究的扩展结局。
Diabetes Technol Ther. 2022 Sep;24(9):611-618. doi: 10.1089/dia.2022.0085. Epub 2022 Jul 11.
5
Frequency of Diabetic Ketoacidosis in Patients with Type 1 Diabetes Using FreeStyle Libre: A Retrospective Chart Review.使用 FreeStyle Libre 的 1 型糖尿病患者中糖尿病酮症酸中毒的频率:一项回顾性图表审查。
Adv Ther. 2021 Jun;38(6):3314-3324. doi: 10.1007/s12325-021-01765-z. Epub 2021 May 19.
6
Reduced Rate of Hospitalizations for Acute Diabetes Events Before and After FreeStyle Libre System Initiation in Some People With Type 2 Diabetes on Insulin-Secretagogue Oral Drug Therapy Without Insulin in France.在法国,一些接受胰岛素促分泌剂口服药物治疗但未使用胰岛素的2型糖尿病患者中,使用FreeStyle Libre系统前后急性糖尿病事件住院率降低。
Diabetes Technol Ther. 2024 Dec;26(12):932-938. doi: 10.1089/dia.2024.0171. Epub 2024 Jul 4.
7
8
FreeStyle Libre Flash Glucose Monitoring system for people with type 1 diabetes in the UK: a budget impact analysis.英国 1 型糖尿病患者使用 FreeStyle Libre Flash 血糖监测系统的预算影响分析。
BMJ Open Diabetes Res Care. 2022 Mar;10(2). doi: 10.1136/bmjdrc-2021-002580.
9
Cost Analysis of FreeStyle Libre 2 System in Type 2 Diabetes Mellitus Population.2型糖尿病患者群体中FreeStyle Libre 2系统的成本分析
Diabetes Ther. 2021 Sep;12(9):2329-2342. doi: 10.1007/s13300-021-01064-4. Epub 2021 May 4.
10
Accuracy of a Professional Continuous Glucose Monitoring Device in Individuals with Type 2 Diabetes Mellitus.专业连续血糖监测设备在 2 型糖尿病患者中的准确性。
Kobe J Med Sci. 2022 Oct 3;68(1):E5-E10.

引用本文的文献

1
Etiologies and Outcomes of Diabetic Ketoacidosis in Cancer Patients: A Retrospective Analysis.癌症患者糖尿病酮症酸中毒的病因及结局:一项回顾性分析
Cancers (Basel). 2025 Aug 22;17(17):2728. doi: 10.3390/cancers17172728.
2
Glucose alarms approach with flash glucose monitoring system: a narrative review of clinical benefits.基于动态葡萄糖监测系统的葡萄糖警报:临床益处的叙述性综述
Diabetol Metab Syndr. 2025 Jul 16;17(1):276. doi: 10.1186/s13098-025-01797-3.
3
Reduced rates of diabetic retinopathy complications with use of continuous glucose monitoring.使用连续血糖监测可降低糖尿病视网膜病变并发症的发生率。
Sci Rep. 2025 Jul 12;15(1):25215. doi: 10.1038/s41598-025-08971-7.
4
Enhancing Type 2 Diabetes Care With CGM Integration: Insights From an Italian Expert Group.通过集成持续葡萄糖监测改善2型糖尿病护理:来自一个意大利专家小组的见解
Diabetes Metab Res Rev. 2025 Jul;41(5):e70059. doi: 10.1002/dmrr.70059.
5
Narrative Review: Continuous Glucose Monitoring (CGM) in Older Adults with Diabetes.叙述性综述:老年糖尿病患者的持续血糖监测(CGM)
Diabetes Ther. 2025 Jun;16(6):1139-1154. doi: 10.1007/s13300-025-01720-z. Epub 2025 Apr 16.
6
The role of advanced technologies in improving diabetes outcomes.先进技术在改善糖尿病治疗效果中的作用。
Am J Manag Care. 2025 Apr 1;31(4):e102-e112. doi: 10.37765/ajmc.2025.89725.
7
Unveiling Pharmacological Promise of (Haribhanga) Peel Extract: Exploring an Untapped Cultivar Through Biochemical and Computational Approaches.揭示(哈里班加)果皮提取物的药理学前景:通过生化和计算方法探索一种未开发的品种。
Scientifica (Cairo). 2025 Mar 10;2025:6516268. doi: 10.1155/sci5/6516268. eCollection 2025.
8
Assessing glycaemic impact of FreeStyle libre monitoring in patients with insulin-treated type 2 diabetes: a retrospective real-world analysis.评估FreeStyle Libre监测对胰岛素治疗的2型糖尿病患者的血糖影响:一项回顾性真实世界分析。
J Diabetes Metab Disord. 2025 Mar 1;24(1):72. doi: 10.1007/s40200-025-01572-1. eCollection 2025 Jun.
9
A systematic literature review on the burden of diabetic ketoacidosis in type 2 diabetes mellitus.关于2型糖尿病中糖尿病酮症酸中毒负担的系统文献综述。
Diabetes Obes Metab. 2025 May;27(5):2750-2767. doi: 10.1111/dom.16282. Epub 2025 Mar 3.
10
Evaluation of glycemia risk index and continuous glucose monitoring-derived metrics in type 1 diabetes: a real-world observational study.1型糖尿病患者血糖风险指数及动态血糖监测指标评估:一项真实世界观察性研究
J Diabetes Metab Disord. 2025 Feb 1;24(1):59. doi: 10.1007/s40200-025-01569-w. eCollection 2025 Jun.

本文引用的文献

1
Trends in Emergency Department Visits and Inpatient Admissions for Hyperglycemic Crises in Adults With Diabetes in the U.S., 2006-2015.2006-2015 年美国糖尿病成人高血糖危象急诊就诊和住院趋势。
Diabetes Care. 2020 May;43(5):1057-1064. doi: 10.2337/dc19-2449. Epub 2020 Mar 11.
2
6. Glycemic Targets: .6. 血糖目标: 。
Diabetes Care. 2020 Jan;43(Suppl 1):S66-S76. doi: 10.2337/dc20-S006.
3
Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study.1 型糖尿病患者接受间歇性扫描连续血糖监测 1 年后的生活质量和血糖控制(FUTURE):一项前瞻性观察性真实世界队列研究。
Diabetes Care. 2020 Feb;43(2):389-397. doi: 10.2337/dc19-1610. Epub 2019 Dec 16.
4
The Long-Term Incidence of Hospitalization for Ketoacidosis in Adults with Established T1D-A Prospective Cohort Study.成人 1 型糖尿病患者酮症酸中毒住院的长期发生率:一项前瞻性队列研究。
J Clin Endocrinol Metab. 2020 Jan 1;105(1). doi: 10.1210/clinem/dgz003.
5
Insulin Pump Combined with Flash Glucose Monitoring: A Therapeutic Option to Improve Glycemic Control in Severely Nonadherent Patients with Type 1 Diabetes.胰岛素泵联合动态血糖监测:改善 1 型糖尿病严重不依从患者血糖控制的治疗选择。
Diabetes Technol Ther. 2019 Jul;21(7):409-412. doi: 10.1089/dia.2019.0041.
6
Marked improvement in HbA following commencement of flash glucose monitoring in people with type 1 diabetes.糖化血红蛋白在 1 型糖尿病患者开始使用瞬感葡萄糖监测后显著改善。
Diabetologia. 2019 Aug;62(8):1349-1356. doi: 10.1007/s00125-019-4894-1. Epub 2019 Jun 9.
7
Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes.实时动态血糖监测技术对 2 型糖尿病患者血糖控制及治疗满意度的影响。
Diabetes Care. 2019 Jul;42(7):1178-1184. doi: 10.2337/dc18-0166. Epub 2019 Apr 29.
8
Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.应用瞬感葡萄糖监测技术(FreeStyle Libre)于 1 型糖尿病青少年患者:AWeSoMe 研究组真实世界观察性经验。
Acta Diabetol. 2018 Dec;55(12):1303-1310. doi: 10.1007/s00592-018-1218-8. Epub 2018 Aug 31.
9
Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study.一项单臂研究中使用瞬感葡萄糖监测技术的 1 型糖尿病患儿和青少年的结果。
Pediatr Diabetes. 2018 Nov;19(7):1294-1301. doi: 10.1111/pedi.12735. Epub 2018 Aug 29.
10
Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis.过去十年美国的医疗保健利用与糖尿病酮症酸中毒负担:一项全国性分析。
Diabetes Care. 2018 Aug;41(8):1631-1638. doi: 10.2337/dc17-1379. Epub 2018 May 17.

法国启动瞬感葡萄糖监测后 1 型或 2 型糖尿病患者急性糖尿病并发症发生率显著下降:RELIEF 研究。

Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study.

机构信息

Department of Diabetology, Endocrinology, and Nutrition, Bichat-Claude Bernard Hospital, Paris, France

Unité INSERM U1138 Immunity and Metabolism in Diabetes, ImMeDiab Team, Centre de Recherches des Cordeliers, Paris, France.

出版信息

Diabetes Care. 2021 Jun;44(6):1368-1376. doi: 10.2337/dc20-1690. Epub 2021 Apr 20.

DOI:10.2337/dc20-1690
PMID:33879536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8247513/
Abstract

OBJECTIVE

The RELIEF study assessed rates of hospitalization for acute diabetes complications in France before and after initiation of the FreeStyle Libre system.

RESEARCH DESIGN AND METHODS

A total of 74,011 patients with type 1 diabetes or type 2 diabetes who initiated the FreeStyle Libre system were identified from the French national claims database with use of ICD-10 codes, from hospitalizations with diabetes as a contributing diagnosis, or the prescription of insulin. Patients were subclassified based on self-monitoring of blood glucose (SMBG) strip acquisition prior to starting FreeStyle Libre. Hospitalizations for diabetic ketoacidosis (DKA), severe hypoglycemia, diabetes-related coma, and hyperglycemia were recorded for the 12 months before and after initiation.

RESULTS

Hospitalizations for acute diabetes complications fell in type 1 diabetes (-49.0%) and in type 2 diabetes (-39.4%) following FreeStyle Libre initiation. DKA fell in type 1 diabetes (-56.2%) and in type 2 diabetes (-52.1%), as did diabetes-related comas in type 1 diabetes (-39.6%) and in type 2 diabetes (-31.9%). Hospitalizations for hypoglycemia and hyperglycemia decreased in type 2 diabetes (-10.8% and -26.5%, respectively). Before initiation, hospitalizations were most marked for people noncompliant with SMBG and for those with highest acquisition of SMBG, which fell by 54.0% and 51.2%, respectively, following FreeStyle Libre initiation. Persistence with FreeStyle Libre at 12 months was at 98.1%.

CONCLUSIONS

This large retrospective study on hospitalizations for acute diabetes complications shows that a significantly lower incidence of admissions for DKA and for diabetes-related coma is associated with use of flash glucose monitoring. This study has significant implications for patient-centered diabetes care and potentially for long-term health economic outcomes.

摘要

目的

RELIEF 研究评估了法国在启用 FreeStyle Libre 系统前后急性糖尿病并发症住院率。

研究设计和方法

从法国国家索赔数据库中使用 ICD-10 代码,根据糖尿病作为合并诊断的住院或胰岛素处方,确定了 74011 名 1 型或 2 型糖尿病患者开始使用 FreeStyle Libre 系统。根据开始使用 FreeStyle Libre 前的自我血糖监测 (SMBG) 条采集情况,对患者进行了亚分类。记录了启用 FreeStyle Libre 前后 12 个月内糖尿病酮症酸中毒 (DKA)、严重低血糖、糖尿病相关昏迷和高血糖的住院情况。

结果

启用 FreeStyle Libre 后,1 型糖尿病 (-49.0%) 和 2 型糖尿病 (-39.4%) 的急性糖尿病并发症住院率下降。1 型糖尿病和 2 型糖尿病的 DKA 分别下降了 (-56.2% 和 -52.1%),1 型糖尿病和 2 型糖尿病的糖尿病相关昏迷分别下降了 (-39.6% 和 -31.9%)。2 型糖尿病的低血糖和高血糖住院率分别下降了 (-10.8% 和 -26.5%)。在开始之前,不符合 SMBG 要求和 SMBG 采集量最高的患者住院情况最为明显,启用 FreeStyle Libre 后,这两种情况分别下降了 54.0% 和 51.2%。12 个月时,FreeStyle Libre 的持续使用率为 98.1%。

结论

这项关于急性糖尿病并发症住院的大型回顾性研究表明,使用即时血糖监测与 DKA 和糖尿病相关昏迷的入院率显著降低相关。这项研究对以患者为中心的糖尿病护理具有重要意义,可能对长期健康经济效益产生影响。